Electric muscle training may tame high blood pressure without pills
NCT ID NCT07406191
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether whole-body electromyostimulation (WB-EMS), a technology that stimulates muscles with mild electrical pulses, can lower resting blood pressure and improve other heart risk factors in overweight adults aged 50+ with mild hypertension. Over 12 weeks, 28 participants either received WB-EMS twice a week for 20 minutes or continued their normal routine. The goal is to see if this time-saving, joint-friendly training can be a safe and effective option for managing blood pressure and metabolic health.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Whole-body electromyostimulation (WB-EMS)
- What this could lead to
- If it works, this could offer a time-efficient, joint-friendly exercise alternative to help manage blood pressure and other heart risk factors.
- What could go wrong
- This is a small, early-stage study with only 28 participants, so results may not apply widely. WB-EMS is not a substitute for medication or lifestyle changes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
28 people
The number who actually took part.
- Started
-
Feb 2026
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
50 to 70 years
- Sex
-
Male participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Grade 1 hypertension: systolic 140 and/or diastolic 90 mmHg * overweight or obese (body mass index \> 25 kg/m2) Exclusion Criteria: * blood pressure-lowering pharmacologic therapy. * WB-EMS application and regular resistance exercise training * Conditions and illnesses that preclude intensive physical exertion * Severe cardiac arrhythmia * Heart failure * acute pulmonary embolism * acute myocarditis * severe hypertension, e.g. blood pressure \> 200 mmHg systolic and/or \>110 mmHg diastolic * Contraindications for bioimpedance analysis (e.g. pacemaker) * Contraindications for WB-EMS application (e.g. acute infections/fever, epilepsy)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Hypercholesterolemia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Faculty of Medicine, University of Tuebingen
Erlangen, 91052, Germany
-
Institute of Radiology, University Hospital Erlangen
Erlangen, 91054, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can pressing six points on the body help older adults sleep?
- Can AI-Tailored heat warnings shield chronic disease patients from dangerous temperatures?
- Can a weekly weight drug quiet gout attacks?
- Can a Once-Daily pill tame bad cholesterol?
- Could a quieter, automated blood pressure check help more people control hypertension?
- Can a phone call boost confidence in managing high blood pressure?